Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-01 9:19 pm Unchanged | 2025-03-31 | 13G | Lipella Pharmaceuticals Inc. LIPO | Leaf Huang | 69,443 2.700% | 0 (Unchanged) | Filing History |
| 2025-04-09 8:43 pm Unchanged | 2025-04-07 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 212,290 4.900% | 0 (Unchanged) | Filing History |
| 2025-04-09 8:39 pm Purchase | 2025-04-07 | 13D | Lipella Pharmaceuticals Inc. LIPO | Michael B. Chancellor | 209,641 4.800% | 1 (+0.00%) | Filing History |
| 2025-04-07 7:20 pm Purchase | 2025-04-03 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 212,290 8.000% | 1 (+0.00%) | Filing History |
| 2025-03-19 6:23 pm Unchanged | 2025-03-17 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 212,289 8.000% | 0 (Unchanged) | Filing History |
| 2025-03-17 8:18 pm Unchanged | 2025-03-13 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 212,289 8.000% | 0 (Unchanged) | Filing History |
| 2025-03-11 8:09 pm Unchanged | 2025-03-10 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 212,289 8.000% | 0 (Unchanged) | Filing History |
| 2025-03-03 5:01 pm Unchanged | 2025-02-28 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 212,289 8.000% | 0 (Unchanged) | Filing History |
| 2025-02-10 5:35 pm Unchanged | 2025-02-06 | 13D | Lipella Pharmaceuticals Inc. LIPO | Michael B. Chancellor | 209,640 7.900% | 0 (Unchanged) | Filing History |
| 2025-02-10 5:32 pm Unchanged | 2025-02-06 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 212,289 8.000% | 0 (Unchanged) | Filing History |
| 2025-01-30 5:28 pm Unchanged | 2025-01-28 | 13D | Lipella Pharmaceuticals Inc. LIPO | Michael B. Chancellor | 209,640 10.000% | 0 (Unchanged) | Filing History |
| 2025-01-30 5:27 pm Unchanged | 2025-01-28 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 212,289 10.100% | 0 (Unchanged) | Filing History |
| 2025-01-23 6:11 pm Purchase | 2025-01-21 | 13D | Lipella Pharmaceuticals Inc. LIPO | Michael B. Chancellor | 209,640 11.500% | 209,640 (New Position) | Filing History |
| 2025-01-23 6:08 pm Unchanged | 2025-01-21 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 212,289 11.700% | 0 (Unchanged) | Filing History |
| 2025-01-17 8:17 pm Unchanged | 2025-01-15 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 212,289 16.200% | 0 (Unchanged) | Filing History |
| 2025-01-03 9:25 pm Unchanged | 2024-12-31 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 212,289 16.200% | 0 (Unchanged) | Filing History |
| 2025-01-03 3:54 pm Sale | 2024-12-31 | 13G | Lipella Pharmaceuticals Inc. LIPO | SABBY MANAGEMENT LLC | 60,325 4.900% | -12,152 (-16.77%) | Filing History |
| 2024-12-27 9:31 pm Purchase | 2024-12-23 | 13D | Lipella Pharmaceuticals Inc. LIPO | Jonathan H. Kaufman | 212,289 16.200% | 212,289 (New Position) | Filing History |
| 2024-11-14 5:09 pm Purchase | 2024-09-30 | 13G | Lipella Pharmaceuticals Inc. LIPO | Gruber Michele | 46,875 3.900% | 46,875 (New Position) | Filing History |
| 2024-11-14 5:00 pm Purchase | 2024-09-30 | 13G | Lipella Pharmaceuticals Inc. LIPO | Leaf Huang | 69,443 5.700% | 69,443 (New Position) | Filing History |